eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	Cancer Genetics, Inc.
Proposed Ticker	CGIX
CUSIP	13739U104
Business Description	A diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer (theranosis).
Lead Underwriter	N/A
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A